Celebrating 30 Years of Excellence

We’ve always been a pioneer. We’ll never stop looking for new ways to live up to our reputation of quality, reliability, and commitment.

  • Our First Cleanroom

    Our First Cleanroom

    CAPS® begins our mission to innovate safe sterile compounding practices by opening our first CAPS cleanroom.   In 1991, many hospital pharmacies had no cleanrooms.
  • Collaborative Pharmacy Services

    Collaborative Pharmacy Services

    CAPS® continues to perfect the practice of sterile compounding through state-of-the-art cleanrooms and a patented computer order-entry system.


    By this time, CAPS has 8 regional pharmacies conducting nationwide “collaborative pharmacy services” with hundreds of hospitals.


    This same year, USP publishes chapter <1206>, an informational chapter on sterile compounding.

  • CAPS Becomes Part of <span style="white-space: nowrap;">B. Braun<span> Medical

    CAPS Becomes Part of B. Braun Medical

    By 1997, CAPS® has voluntarily registered its 11 pharmacy locations with the FDA.


    This same year, CAPS is acquired by B. Braun Medical.


    To provide the FDA with more oversight over large-scale pharmacy compounding, Congress passes FDAMA. In later years, FDAMA is struck down by the U.S. Supreme Court.

  • Protecting Against the Risk of Error

    Protecting Against the Risk of Error

    CAPS® develops solutions to protect patients from order transcription errors as most of the world is consumed with the Y2K scare.


    Our current web-based ordering platform, and our electronic hospital interfaces, originated from our first “modem and DOS” program that was designed to avoid the risks of faxed orders.

  • Quality of the Highest Standard

    Quality of the Highest Standard

    USP publishes <797>, the first USP chapter to contain enforceable sterile compounding requirements.


    By 2004, many CAPS® quality standards had already surpassed USP <797>.

  • 503B is Launched

    503B is Launched

    Anticipating the 503B Model, and focused on safety and quality, CAPS® launches one of the first successful FDA-registered 503B outsourcing facilities.


    In an effort to provide predictability and transparency in the process of sterile compounding, Congress enacts the Drug Quality and Security Act, dividing compounding into 503A (patient-specific) and 503B (large-scale).

  • Delivering Solutions. Delivering Confidence.

    Delivering Solutions. Delivering Confidence.

    Today, CAPS® has America’s largest network of 503A pharmacies. We have three state-of-the-art 503B outsourcing facilities.


    We offer same-day service and delivery. We have 14 different product lines. We continue to find innovative new ways to deliver solutions and deliver confidence.